Showing results (131-140 of 217) with videos related to

Sort By:
Pageof 22
Blood|August 9, 2001
Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopeniaJ L Teeling, T Jansen-Hendriks, T W Kuijpers, et al.
Immunology|December 1, 1994
Role of neutrophil Fc gamma RIIa (CD32) and Fc gamma RIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytesR G Bredius, C A Fijen, M De Haas, et al.
Rhinology|March 6, 2024
The effect of smell training on COVID-19 induced smell lossE J A Schepens, C J M de Haas, E M Postma, et al.
Thrombosis and Haemostasis|November 19, 1997
Sensitive measurement of thrombopoietin by a monoclonal antibody based sandwich enzyme-linked immunosorbent assayC C Folman, A E von dem Borne, I H Rensink, et al.
Seminars in Immunopathology|June 30, 2021
Halting targeted and collateral damage to red blood cells by the complement systemM Jalink, E C W de Boer, D Evers, et al.
British Journal of Haematology|July 27, 2001
The role of thrombopoietin in post-operative thrombocytosisC C Folman, M Ooms, B Kuenen B, et al.
British Journal of Cancer|August 1, 1995
Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cellsE W Eijdems, G J Zaman, M de Haas, et al.
Gut|April 1, 1996
Soluble Fc gamma receptor III (CD 16) and eicosanoid concentrations in gut lavage fluid from patients with inflammatory bowel disease: reflection of mucosal inflammationD W Hommes, J Meenan, M de Haas, et al.
Frontiers in Immunology|May 31, 2021
Therapeutic Liposomal Vaccines for Dendritic Cell Activation or ToleranceNoémi Anna Nagy, Aram M de Haas, Teunis B H Geijtenbeek, et al.
The Journal of Infectious Diseases|October 1, 1994
Fc gamma receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infectionsL A Sanders, J G van de Winkel, G T Rijkers, et al.
Pageof 22